Clinical Trials Logo

Leg Ulcer clinical trials

View clinical trials related to Leg Ulcer.

Filter by:

NCT ID: NCT00998673 Terminated - Venous Ulcer Clinical Trials

Silica Gel Fiber Wound Dressing for Chronic Venous Leg Ulcers

Start date: April 2009
Phase: Phase 2
Study type: Interventional

Silica Gel Fiber is a bioresorbable, inorganic silica gel fibre patch promoting skin tissue growth and enhanced wound healing for all types of chronic wounds. It is applied as patch and will be hold in place by a secondary dressing for maintaining the moist wound environment. The study is aimed to demonstrate superiority over a standard wound treatment for chronic venous leg ulcers. The primary efficacy variable is time to healing.

NCT ID: NCT00823095 Terminated - Clinical trials for Chronic Ulcer of Lower Extremity

Topical Nitric Oxide Trial in Chronic Non-Healing Wounds

Start date: December 2005
Phase: Phase 2
Study type: Interventional

To determine the effects of topically applied ViaNOx-H for 8 hours daily for 2 weeks on the reduction of the bio-burden in biofilms on chronic non-healing wounds as recorded by measurements of wound size and wound culture.

NCT ID: NCT00771368 Terminated - Pressure Ulcer Clinical Trials

Reduction of Bacteria in MRSA Positive Ulcers

Start date: January 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if gaseous nitric oxide is effective in the treatement of bacteria in MRSA positive ulcers

NCT ID: NCT00762138 Terminated - Wounds Clinical Trials

The AutoloGelâ„¢ Post-Market Surveillance (TAPS) Program

TAPS
Start date: September 2008
Phase: N/A
Study type: Interventional

AutoloGelâ„¢ Post-Market Surveillance Program Purpose:Evaluate the incidence of hematologic and immunologic adverse events, including coagulopathies in patients with wounds to which AutoloGelâ„¢ was applied. Design:Prospective, open label, patient registry. Investigator Sites: 3 Enrollment Size: 300 Subject Population: Patients with exuding wounds, such as leg ulcers, pressure ulcers, and diabetic ulcers and for the management of mechanically or surgically-debrided wounds. Primary Objective Safety: Assess the incidence of hematologic (coagulopathies), immunologic (including anaphylaxis) and other adverse events associated with the application of AutoloGel on exuding wounds, such as leg ulcers, pressure ulcers and diabetic ulcers and during the management of mechanically or surgically-debrided wounds. Primary Safety Endpoint: Absence of coagulopathies caused by inhibitors to coagulation Factor V as determined by a significant prolongation of the prothrombin (PT) time and confirmed by severe depletion of Factor V activity with a positive Bethesda Assay for anti-Factor V functional inhibitors.

NCT ID: NCT00545298 Terminated - Venous Ulcers Clinical Trials

Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers

Start date: October 2007
Phase: Phase 2
Study type: Interventional

This study will test the safety and efficacy of nitric oxide gas in the treatment of venous leg ulcers